Impact of prenatal screening and diagnostic testing on trends in Down syndrome births and terminations in Western Australia 1980 to 2013
Authors:
- 28 September 2015
- journal article
- research article
- Published by Wiley in Prenatal Diagnosis
- Vol. 35 (13) , 1324-1330
Abstract
Objective To assess how prenatal screening and diagnostic testing have impacted the diagnosis, termination and birth prevalence of Down syndrome in Western Australia (1980–2013). Method We analysed trends in termination rates and birth prevalence of Down syndrome using aggregated data (1980–2013). We modelled the expected live-birth rate and prevalence of Down syndrome and compared different eras of screening and diagnosis with respect to the impact on live-birth rate and prevalence of Down syndrome. Results Between 1980 and 2013, the rate of Down syndrome pregnancies increased, corresponding to a greater proportion of babies born to older women. Following the introduction of screening in 1994, the rate of live-born infants with Down syndrome reduced significantly (p = 0.001). The rate of terminations of pregnancy for Down syndrome remained stable over this period. In the absence of termination, the Down syndrome live-birth rate would have risen from 1.1 per 1000 to 2.17 per 1000 between 1980 and 2013. Conclusion Prenatal testing in Western Australia has reduced the birth prevalence of Down syndrome despite an increased rate of Down syndrome pregnancies. Most women for whom a prenatal diagnosis of fetal Down syndrome is made, chose to terminate the pregnancy (93%), and this proportion has not changed over the study period. © 2015 John Wiley & Sons, Ltd.Keywords
This publication has 15 references indexed in Scilit:
- Positive predictive values for detection of trisomies 21, 18 and 13 and termination of pregnancy rates after referral for advanced maternal age, first trimester combined test or ultrasound abnormalities in a national screening programme (2007-2009)Prenatal Diagnosis, 2013
- Impact of observed versus hypothesized service utilization on the incremental cost of first trimester screening and prenatal diagnosis for trisomy 21 in a Canadian provincePrenatal Diagnosis, 2013
- Non-Invasive Prenatal Genetic Testing: A Study of Public AttitudesPublic Health Genomics, 2011
- First-trimester screening for trisomy 21 in Denmark: implications for detection and birth rates of trisomy 18 and trisomy 13Ultrasound in Obstetrics & Gynecology, 2011
- Socio-demographic disparities in the uptake of prenatal screening and diagnosis in Western AustraliaAustralian and New Zealand Journal of Obstetrics and Gynaecology, 2010
- International trends of Down syndrome 1993–2004: Births in relation to maternal age and terminations of pregnanciesBirth Defects Research Part A: Clinical and Molecular Teratology, 2010
- Ethical challenges in providing noninvasive prenatal diagnosisCurrent Opinion in Obstetrics and Gynecology, 2010
- Regional variations in prenatal screening across Australia: Stepping towards a national policy frameworkAustralian and New Zealand Journal of Obstetrics and Gynaecology, 2006
- Maternal age‐specific fetal loss rates in Down syndrome pregnanciesPrenatal Diagnosis, 2006
- Cost utility of prenatal diagnosis and the risk-based thresholdThe Lancet, 2004